November 14, 2011 – The American Society of Echocardiography (ASE) reported that the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) has recognized the value of contrast agents in echocardiography and made very positive revisions to the U.S. label for Definity, an ultrasound contrast agent produced by Lantheus Medical Imaging.

CardioDefender Diagnostic System

November 11, 2011 – MedaPhor, the United Kingdom-based ultrasound simulation company, announced that the University of Washington Medical Center in Seattle is the first United States hospital to install its revolutionary ScanTrainer ultrasound simulation system.

Intelerad Medical Systems will unveil all-new collaboration and personalization capabilities in IntelePACS 4.4 at the RSNA annual meeting, Nov. 27-Dec. 2 in Chicago. The new features, which will be showcased for the first time at the conference, include multi-level critical alerts, radiologist chat features, powerful navigation and layout tools and voice-activated commands.

Cardiosave Intra-aortic Balloon Pump

Subscribe Now